# data[].attributes.body
INVU by Nuvo: Expanding Electronic Fetal Monitoring Options

# data[].attributes.body
INVU by Nuvo is a novel, remote fetal monitoring system that represents a new use of wearable technology in pregnancy. It is designed for patients who require additional or extensive monitoring outside of the routine course of care. INVU is a prescription-only, FDA-cleared medical device that gathers data on fetal heart rate, maternal heart rate, and uterine activity (contractions) through the application of a wearable belt containing multiple sensors and monitors (Walter et al., 2022). The data is transmitted wirelessly through cloud-based servers, analyzed by AI-driven learning algorithms, and interpreted by the patient's healthcare provider to evaluate fetal well-being (Nuvo, n.d.). It first received FDA 510(k) clearance in March 2020 to monitor maternal and fetal heart rates, and additional clearance in 2021 to include uterine activity monitoring (Walter et al., 2022). With the inclusion of uterine activity, the second clearance enables non-stress tests (NST)- a common screening for fetal well-being that includes contractions- to be performed remotely in locations other than the clinic or hospital. The FDA has cleared its use for singleton pregnancies 32 weeks gestation or greater (U.S. Food and Drug Administration, 2021). The monitors provide useful (but not overly excessive) information to the patient on the corresponding mobile app while providers view and interpret the session in real time (Nuvo, n.d.). For patients needing multiple non-stress tests each week (such as those with complications or high-risk pregnancies), INVU provides the option to complete these screenings without needing to leave their home or miss work.

# data[].attributes.body
Noninvasive, FDA- cleared medical device (Hamm et al., 2023)

Compared to other technologies that may be used remotely (handheld fetal Doppler, telemetry, ultrasound), INVU is the only device that assesses both FHR and uterine activity monitoring, both of which are required for NST screening

Provides opportunity for remote monitoring from home or work, decreasing need to travel to clinic for visits

Research has shown comparable performance to standard methods of EFM monitoring (cardiotocography, intrauterine pressure catheter) (Walter et al., 2022)

Increased access to care for patients with barriers, such as those in rural or underserved areas

Promotes patient engagement by providing data and insights regarding fetal and maternal health

Beneficial for patients with restrictions (such as those on bedrest) who should decrease travel (Nuvo Cares, 2022)

Remote monitoring introduces the potential for reduced healthcare costs compared to management in hospital (Zizzo et al., 2021)

# data[].attributes.body
Cost of use may be a barrier for some patients

Requires a prescription from provider and access to a stable internet connection for transmission of data (Nuvo, n.d.)

Not cleared for use by all patients, such as those with twins or earlier than 32 weeks gestation (Walter et al., 2022)

Remote monitoring may produce incorrect data if the patient does not apply or use the device correctly (Stricker et al., 2025)

Further research is needed to establish health benefits associated with use (Walter et al., 2022)

Data privacy concerns exist as with all other wearable devices that utilize cloud storage or analytics (Stricker et al., 2025)

# data[].attributes.body
(Nuvo Cares | Remote Premium Pregnancy Monitoring, 2022)

# data[].attributes.attachment_link.authors[].name
Nuvo Cares | Remote Premium Pregnancy Monitoring

# data[].attributes.body
My top 5 CliftonStrengths are Relator, Harmony, Deliberative, Empathy and Consistency.

My Relator strength allows me to promote relationship-building and cohesiveness for the team, further enhancing our efforts at providing an accurate evaluation of the innovation.

My Harmony strength is a relationship-building strength as well and makes me a strong negotiator. I can use this strength to foster conflict resolution among team members.

Empathy is an intuitive sense that allows me to connect more deeply with the other team members. This strength helps me “read the room” and the vibe amongst the other team members, further facilitating my team-management skills.

I have two strengths in the Executing Domain: Deliberative and Consistency. Applying my Deliberative strength means that I am very thoughtful when it comes to making serious decisions, and I plan for all possibilities. This strength helps my team because I can identify risks and provide perspectives that my team members may not have considered.

When I execute my Consistency strength, I am promoting the idea that policies should be adhered to, and everyone should be treated fairly across the board. In a team setting, this strength helps me to enforce equal treatment for all the members of my team based on guidelines and balance.

# data[].attributes.body
To complete my evaluation team, I chose Alice, Angelica, Carter, Izzie and Matthew. These members were chosen because of their ability to create a balanced team among the four strengths domains, including myself.

As an Achiever, Alice is a hard worker dedicated to the productivity of the group. This Executing strength will help ensure that tasks are accomplished at an appropriate pace.

Angelica’s Analytical strength inspires her to understand the way things work. Being data-driven, this Strategic Thinking strength brings insight and comprehension to the group’s evaluation efforts.

Carter’s Communication strength is the perfect Influencing strength for turning ideas and thoughts into words and makes him an indispensable team member when it comes to presenting the team’s evaluation findings.

With her Input strength, Izzie will seek and collect a wealth of information on the innovative technology. This Strategic Thinking strength allows for her to improve analyzation related to the team’s evaluation.

Matthew’s Maximizer strength encourages him to seek ways to improve the group’s efforts. At its best, this Influencing strength fosters the group’s success by focusing on its strongest talents.

# data[].attributes.body
Although INVU is a wearable device, its innovation lies in the development of a new method for completing an in-clinic surveillance test (NST) outside of its traditional setting. I chose this technology because it has applications to my professional and personal life. As a previous labor and delivery nurse for nearly 9 years, I can see the practicality of remote electronic fetal monitoring, specifically non-stress tests. With the capability to simultaneously measure both fetal heart rate and uterine activity, INVU is currently the only FDA-cleared medical device that can complete this task. There are no other similar wearable technologies available for home use. For the patient, it may be easier and more comfortable to have the option to use INVU remotely during scheduled non-stress tests or in the case of possible pre-triage workups under the guidance of their provider. For the providers, the ability to assess their patients’ NSTs without having the patient in the office can save time and reduce clinical workload. The unit I worked on, and its associated clinics, had a very high patient volume. Utilization of remote monitoring can improve the workflow for both staff and patients, resulting in more timely interventions and improved outcomes of care.  It can increase patient compliance by reducing barriers to care that would prevent a patient from making it into the office. Many of the patients I treated would travel from all over the surrounding area, sometimes from distances up to 2 hours away. Providing them with the ability to be monitored from home would greatly improve their satisfaction with their care.

I also have personal interests in this technology because I am currently a patient who fits the protocol for use. In my own high-risk pregnancy, I travel to my doctor's office for fetal surveillance procedures twice a week. If I were able to complete my non-stress tests from the comfort of my home, it would reduce travel time and the associated hassle. I will acknowledge, however, that I am not in the typical patient category. I have extensive knowledge of and experience with fetal monitoring. Therefore, I understand better how to use such technology at home, as well as its implications. For patients using INVU, extensive education should be provided so that the technology can be used correctly. It is also essential to provide patient education regarding urgent and emergent conditions of pregnancy. This is necessary so that patients can distinguish scenarios that necessitate in-person assessment.

INVU is a novel, innovative technology that delivers clinically accurate data not available from consumer-grade wearable devices. It has the potential to reduce clinical workload and increase access to care for patients facing barriers with transportation, distance, work schedules, or other issues. I look forward to seeing further research on the potential health benefits and improved outcomes for pregnancies where remote electronic fetal monitoring is used. I believe technological advances such as INVU can improve standards of obstetric care in today's evolving healthcare setting.